“Efficacy and Safety of Fixed-Dose-Rate Infusions of Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer”, J. Anal. Oncol., vol. 4, no. 1, pp.  44–51, Jan. 2015, doi: 10.6000/1927-7229.2015.04.01.8.